KEIO RESEARCHERS INFORMATION SYSTEM

Academic Degrees 【 Display / hide 】

Academic Degrees 【 Display / hide 】

• 博士（医学）, International University of Health and Welfare, Coursework, 2022.03

Licenses and Qualifications 【 Display / hide 】

Licenses and Qualifications 【 Display / hide 】

• 医師免許, 2014.03

• 労働衛生コンサルタント, 2019.03

Research Areas 【 Display / hide 】

Research Areas 【 Display / hide 】

• Humanities & Social Sciences / Sociology of science, history of science and technology

• Life Science / Psychiatry

• Life Science / Medical management and medical sociology

• Life Science / Hygiene and public health (non-laboratory)

• Informatics / Life, health and medical informatics

Books 【 Display / hide 】

Books 【 Display / hide 】

• 今日の治療指針 2023年版: 私はこう治療している

  医学書院, 2023.01,  Page： 2121

  Scope: 日本におけるオンライン診療の現状と課題, 海外の動静,  Contact page： 1883-1886

• 今日の治療指針 2023年版[ポケット判]: 私はこう治療している

  医学書院, 2023.01,  Page： 2119

  Scope: 日本におけるオンライン診療の現状と課題, 海外の動静,  Contact page： 1883-1886

• 先進医療NAVIGATOR 医療とAI最前線

  編集:先進医療フォーラム, 日本医学出版, 2022.02,  Page： 84

  Scope: 精神医学領域におけるAI技術の活用,  Contact page： 34-36

• 2022年版 オンライン診療サービスの現状と将来展望

  シード・プランニング, 2021.10,  Page： 401

  Contact page： 285-293

• 必見！オンライン診療の実践と解説

  編著:蝶名林直彦, 日本医事新報社, 2021.06,  Page： 216

  Scope: 精神科領域におけるオンライン診療,  Contact page： 139-147

display all >>

Papers 【 Display / hide 】

Papers 【 Display / hide 】

• Associations between glycemic variability, sleep quality, and daily steps in subjects without diabetes using wearable devices

  Jun Inaishi, Kazuhiro Kashiwagi, Shotaro Kinoshita, Yasuyo Wada, Sayaka Hanashiro, Kiko Shiga, Momoko Kitazawa, Shiori Tsutsumi, Hiroyuki Yamakawa, Taishiro Kishimoto

  Metabolism Open 20   100263 - 100263 2023.12

  Joint Work, Accepted,  ISSN  2589-9368

  • Access to Document (DOI)

• Assessment of glycemic variability and lifestyle behaviors in healthy nondiabetic individuals according to the categories of body mass index

  Kazuhiro Kashiwagi, Jun Inaishi, Shotaro Kinoshita, Yasuyo Wada, Sayaka Hanashiro, Kiko Shiga, Momoko Kitazawa, Shiori Tsutsumi, Hiroyuki Yamakawa, Junichiro Irie, Taishiro Kishimoto

  PLOS ONE （Public Library of Science (PLoS))  18 （ 10 ） e0291923 - e0291923 2023.10

  Joint Work, Accepted

  　View Summary

  Background
  
  There are limited data about the association between body mass index (BMI), glycemic variability (GV), and life-related factors in healthy nondiabetic adults.
  
  Methods
  
  This cross-sectional study was carried out within our ethics committee-approved study called “Exploring the impact of nutrition advice on blood sugar and psychological status using continuous glucose monitoring (CGM) and wearable devices”. Prediabetes was defined by the HbA1c level of 5.7–6.4% and /or fasting glucose level of 100–125 mg/dL. Glucose levels and daily steps were measured for 40 participants using Free Style Libre and Fitbit Inspire 2 under normal conditions for 14 days. Dietary intakes and eating behaviors were assessed using a brief-type self-administered dietary history questionnaire and a modified questionnaire from the Obesity Guidelines.
  
  Results
  
  All indices of GV were higher in the prediabetes group than in the healthy group, but a significant difference was observed only in mean amplitude of glycemic excursions (MAGE). In the multivariate analysis, only the presence of prediabetes showed a significant association with the risk of higher than median MAGE (Odds, 6.786; 95% CI, 1.596–28.858; P = 0.010). Additionally, the underweight (BMI < 18.5) group had significantly higher value in standard deviation (23.7 ± 3.5 vs 19.8 ± 3.7 mg/dL, P = 0.038) and coefficient variability (22.6 ± 4.6 vs 18.4 ± 3.2%, P = 0.015), compared to the normal group. This GV can be partially attributed to irregularity of eating habits. On the contrary, the overweight (BMI ≥ 25) group had the longest time above the 140 or 180 mg/dL range, which may be due to eating style and taking fewer steps (6394 ± 2337 vs 9749 ± 2408 steps, P = 0.013).
  
  Conclusions
  
  Concurrent CGM with diet and activity monitoring could reduce postprandial hyperglycemia through assessment of diet and daily activity, especially in non- normal weight individuals.

  • Access to Document (DOI)

• Conspiracy Theories, Anti-Science, and Anti-Medicine in the COVID-19 Pandemic

  Shotaro Kinoshita

  CBEL Report （東京大学生命倫理連携研究機構)  6 （ 1 ） 80 - 81 2023.07

  Single Work, Accepted

• Telepsychiatry vs. Face-to-Face Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  Hagi Katsuhiko, Kurokawa Shunya, Takamiya Akihiro, Fujikawa Mayu, Kinoshita Shotaro, Iizuka Mari, Furukawa Shota, Eguchi Yoko, Kishimoto Taishiro

  The British Journal of Psychiatry (in press) （ 3 ） 407 - 414 2023.05

  Joint Work, Accepted

  　View Summary

  BACKGROUND: The COVID-19 pandemic has transformed healthcare significantly and telepsychiatry is now the primary means of treatment in some countries. AIMS: To compare the efficacy of telepsychiatry and face-to-face treatment. METHOD: A comprehensive meta-analysis comparing telepsychiatry with face-to-face treatment for psychiatric disorders. The primary outcome was the mean change in the standard symptom scale scores used for each psychiatric disorder. Secondary outcomes included all meta-analysable outcomes, such as all-cause discontinuation and safety/tolerability. RESULTS: We identified 32 studies (n = 3592 participants) across 11 mental illnesses. Disease-specific analyses showed that telepsychiatry was superior to face-to-face treatment regarding symptom improvement for depressive disorders (k = 6 studies, n = 561; standardised mean difference s.m.d. = -0.325, 95% CI -0.640 to -0.011, P = 0.043), whereas face-to-face treatment was superior to telepsychiatry for eating disorder (k = 1, n = 128; s.m.d. = 0.368, 95% CI 0.018-0.717, P = 0.039). No significant difference was seen between telepsychiatry and face-to-face treatment when all the studies/diagnoses were combined (k = 26, n = 2290; P = 0.248). Telepsychiatry had significantly fewer all-cause discontinuations than face-to-face treatment for mild cognitive impairment (k = 1, n = 61; risk ratio RR = 0.552, 95% CI 0.312-0.975, P = 0.040), whereas the opposite was seen for substance misuse (k = 1, n = 85; RR = 37.41, 95% CI 2.356-594.1, P = 0.010). No significant difference regarding all-cause discontinuation was seen between telepsychiatry and face-to-face treatment when all the studies/diagnoses were combined (k = 27, n = 3341; P = 0.564). CONCLUSIONS: Telepsychiatry achieved a symptom improvement effect for various psychiatric disorders similar to that of face-to-face treatment. However, some superiorities/inferiorities were seen across a few specific psychiatric disorders, suggesting that its efficacy may vary according to disease type.

  • Access to Document (DOI)

• Challenges for the appropriate dissemination of products using ingredients derived from cannabis in Japan: Focusing on cannabidiol (CBD)

  Shotaro Kinoshita

  保健医療科学 （国立保健医療科学院)  71 （ 5 ） 440 - 446 2022.12

  Single Work, Accepted

display all >>

Reviews, Commentaries, etc. 【 Display / hide 】

Reviews, Commentaries, etc. 【 Display / hide 】

• Dementia in Japan: a societal focus

  Shotaro Kinoshita, Taishiro Kishimoto

  The Lancet Neurology (Elsevier BV)  22 ( 12 ) 1101 - 1102 2023.12

  Joint Work,  ISSN  1474-4422

  • Access to Document (DOI)

• The use of a national identification system to prevent misuse of benzodiazepines and Z-drugs in Japan

  Shotaro Kinoshita, Taishiro Kishimoto

  Lancet Psychiatry 10 ( 10 ) e26 - e26 2023.10

  Joint Work

  • Access to Document (DOI)

• Clinical assessment with digital devices in psychiatry

  木下翔太郎, 高橋真也, 岸本泰士郎

  臨床精神医学 52 ( 10 ) 1227 - 1233 2023.10

  Joint Work

• 精神科領域のオンライン診療とAI利用

  木下翔太郎, 岸本泰士郎

  医学のあゆみ (医歯薬出版株式会社)  287 ( 2 ) 130 - 135 2023.10

  Joint Work

• AIを使用した精神科診療の最先端

  木下翔太郎, 岸本泰士郎

  精神科 Resident (先端医学社)  4 ( 3 ) 91 - 91 2023.10

  Joint Work

display all >>

Presentations 【 Display / hide 】

Presentations 【 Display / hide 】

• 医療DX・オンライン診療を取り巻く政策動向

  木下翔太郎

  第119回日本精神神経学会学術総会, 

  2023.06

  , 

  Symposium, workshop panel (nominated)

• 離島・僻地におけるオンライン精神科医療の可能性

  木下翔太郎

  第119回日本精神神経学会学術総会, 

  2023.06

  , 

  Symposium, workshop panel (nominated)

• Trends in well-being quantification technologies and ethical, legal, and social issues (ELSI)

  Shotaro Kinoshita

  SPT 2023: The 23rd Biennial Conference in Tokyo, 

  2023.06

  , 

  Oral presentation (general)

• 対面診療に対する遠隔精神医療の治療効果の比較 : ランダム化比較試験に基づくシステマティックレビューとメタアナリシス

  飯塚真理, 萩勝彦, 黒川駿哉, 高宮彰紘, 藤川真由, 木下翔太郎, 古川渉太, 江口洋子, 岸本泰士郎

  第44回日本生物学的精神医学会年会・第32回日本臨床精神神経薬理学会年会・第52回日本神経精神薬理学会年会・第6回日本精神薬学会総会 4学会合同年会（BPCNPNPPP4学会合同年会）, 

  2022.11

  , 

  Poster presentation

• 対面診療に対する遠隔精神医療の治療効果の比較 : ランダム化比較試験に基づくシステマティックレビューとメタアナリシス

  木下翔太郎, 萩勝彦, 黒川駿哉, 高宮彰紘, 藤川真由, 飯塚真理, 古川渉太, 江口洋子, 岸本泰士郎

  第26回日本遠隔医療学会学術大会, 

  2022.10

  , 

  Oral presentation (general)

display all >>